Michael J Bradley Selected Research

mevociclib

1/2019

Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Bradley Research Topics

Disease

1	Cataract (Cataracts) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 07/2006
1	Carcinoma (Carcinomatosis) 07/2006
1	Wounds and Injuries (Trauma) 01/2006
1	Burns 01/2006

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2006
1	mevociclibIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Heparin (Liquaemin)FDA LinkGeneric 07/2006
1	AntibodiesIBA 07/2006
1	NucleolinIBA 07/2006
1	Proto-Oncogene Proteins c-metIBA 07/2006
1	AndrogensIBA 07/2006
1	Sepharose (Agarose)IBA 07/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2006
1	Laminin (Merosin)IBA 07/2006
1	Conditioned Culture MediaIBA 07/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2006

Therapy/Procedure

2	Phacoemulsification 01/2021 - 01/2006
1	Lasers (Laser) 01/2021